Takeda Pharmaceutical Company (TAK)
NYSE:TAK
Holding TAK?
Track your performance easily

Takeda Pharmaceutical Company (TAK) Financial Statements

1,217 Followers

Takeda Pharmaceutical Company Financial Overview

Takeda Pharmaceutical Company's market cap is currently ―. The company's EPS TTM is $0.31; its P/E ratio is 47.74; and it has a dividend yield of 3.79%. Takeda Pharmaceutical Company is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--¥ 1.10T¥ 1.00T¥ 972.47B
Gross Profit--¥ 760.58B¥ 696.86B¥ 679.58B
EBIT--¥ 186.90B¥ 118.35B¥ 210.94B
EBITDA--¥ 363.78B¥ 286.18B¥ 369.23B
Net Income Common Stockholders--¥ 119.13B¥ 61.74B¥ 105.01B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 457.80B¥ 632.70B¥ 726.61B¥ 830.07B¥ 664.53B
Total Assets¥ 15.11T¥ 13.96T¥ 13.50T¥ 14.59T¥ 14.07T
Total Debt¥ 4.84T¥ 4.38T¥ 4.29T¥ 4.74T¥ 4.60T
Net Debt¥ 4.39T¥ 3.75T¥ 3.56T¥ 3.91T¥ 3.94T
Total Liabilities¥ 7.83T¥ 9.28T¥ 7.33T¥ 7.88T¥ 7.75T
Stockholders Equity¥ 7.27T¥ 4.68T¥ 6.18T¥ 6.71T¥ 6.32T
Cash Flow-
Free Cash Flow--¥ 327.61B¥ 180.38B¥ -14.13B
Operating Cash Flow--¥ 378.23B¥ 220.99B¥ 84.24B
Investing Cash Flow--¥ -46.69B¥ -27.21B¥ -94.71B
Financing Cash Flow--¥ -434.95B¥ -51.88B¥ -215.72B
Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History

Takeda Pharmaceutical Company Debt to Assets

Takeda Pharmaceutical Company Cash Flow

Takeda Pharmaceutical Company Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis